Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deanna M Mudie

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Pharmaceutics|September 9, 2010
Physiological parameters for oral delivery and in vitro testingDeanna M Mudie, Gordon L Amidon, Gregory E Amidon
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 4, 2014
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVCYasuhiro Tsume, Deanna M Mudie, Peter Langguth, et al.
Biopharmaceutics & Drug Disposition|August 1, 2012
Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatusDeanna M Mudie, Yi Shi, Haili Ping, et al.
The AAPS Journal|January 29, 2020
Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological PropertiesDeanna M Mudie, Nasim Samiei, Derrick J Marshall, et al.
Molecular Pharmaceutics|September 4, 2020
Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution VesselNiloufar Salehi, Jozef Al-Gousous, Deanna M Mudie, et al.
Pharmaceutics|December 28, 2021
Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. <i>Pharmaceutics</i> 2021, <i>13</i>, 1257Deanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Pharmaceutics|August 28, 2021
In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion TabletsDeanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Molecular Pharmaceutics|April 26, 2017
Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product FormulationsAaron M Stewart, Michael E Grass, Deanna M Mudie, et al.
Pharmaceutics|April 30, 2021
Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in DogsDeanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Molecular Pharmaceutics|August 25, 2020
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; <i>In Vivo</i> and <i>In Vitro</i> AssessmentDeanna M Mudie, Aaron M Stewart, Nishant Biswas, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Pharmaceutics|September 9, 2010
Physiological parameters for oral delivery and in vitro testingDeanna M Mudie, Gordon L Amidon, Gregory E Amidon
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|February 4, 2014
The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVCYasuhiro Tsume, Deanna M Mudie, Peter Langguth, et al.
Biopharmaceutics & Drug Disposition|August 1, 2012
Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatusDeanna M Mudie, Yi Shi, Haili Ping, et al.
The AAPS Journal|January 29, 2020
Selection of In Vivo Predictive Dissolution Media Using Drug Substance and Physiological PropertiesDeanna M Mudie, Nasim Samiei, Derrick J Marshall, et al.
Molecular Pharmaceutics|September 4, 2020
Hierarchical Mass Transfer Analysis of Drug Particle Dissolution, Highlighting the Hydrodynamics, pH, Particle Size, and Buffer Effects for the Dissolution of Ionizable and Nonionizable Drugs in a Compendial Dissolution VesselNiloufar Salehi, Jozef Al-Gousous, Deanna M Mudie, et al.
Pharmaceutics|December 28, 2021
Correction: Mudie et al. In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets. <i>Pharmaceutics</i> 2021, <i>13</i>, 1257Deanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Pharmaceutics|August 28, 2021
In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion TabletsDeanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Molecular Pharmaceutics|April 26, 2017
Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product FormulationsAaron M Stewart, Michael E Grass, Deanna M Mudie, et al.
Pharmaceutics|April 30, 2021
Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in DogsDeanna M Mudie, Aaron M Stewart, Jesus A Rosales, et al.
Molecular Pharmaceutics|August 25, 2020
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; <i>In Vivo</i> and <i>In Vitro</i> AssessmentDeanna M Mudie, Aaron M Stewart, Nishant Biswas, et al.
Pageof 2